You are here: Industry Insights > Alembic

News List

Alembic Pharmaceuticals receives US FDA tentative approval for Dronedarone tablets ExpressPharma
January 11, 2022
Dronedarone is indicated to reduce the risk of hospitalisation for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation
Alembic Pharmaceuticals receives US FDA tentative approval for Vortioxetine tablets ExpressPharma
January 07, 2022
The tablets are indicated for the treatment of Major Depressive Disorder (MDD)
Alembic Pharmaceuticals’s joint venture Aleor Dermaceuticals receives US FDA final approval for Mupirocin Cream USP, 2% ExpressPharma
November 19, 2021
Alembic Pharmaceuticals yesterday announced that its joint venture Aleor Dermaceuticals (Aleor) has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA)...
Alembic Pharmaceuticals gets USFDA approval for Clomipramine Hydrochloride Capsules expresspharma
August 06, 2021
The capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD).
Alembic Pharma Q1 net profit declines to Rs 165 cr expresspharma
July 29, 2021
The company had posted a net profit of Rs 301.46 crores for the corresponding period of the previous fiscal, Alembic Pharmaceuticals said in a regulatory filing.
Alembic Pharmaceuticals gets USFDA final approval for Erlotinib Tablets expresspharma
July 09, 2021
Erlotinib Tablets are indicated for the treatment of patients with metastatic non-small cell lung cancer and locally advanced, unresectable or metastatic pancreatic cancer.
Alembic Pharma gets USFDA final nod for Desipramine Hydrochloride Tablets USP expresspharma
July 09, 2021
Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Desipramine Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg.
Alembic Pharma gets USFDA final approval for Nitrofurantoin Capsules, USP (Macrocrystals) expresspharma
July 02, 2021
The capsules are specifically indicated for the treatment of urinary tract infections when due to susceptible strains of Escherichia coli, enterococci, Staphylococcus aureus, and certain susceptible strains of Klebsiella and Enterobacter species.
Aleor Dermaceuticals gets USFDA nod for Testosterone Topical Solution expresspharma
June 18, 2021
It is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone: Primary hypogonadism and Hypogonadotropic hypoqonadisrn.
Alembic Pharma gets USFDA Final nod for Lurasidone Hydrochloride Tablets expresspharma
May 17, 2021
They are indicated for monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar I disorder (bipolar depression).

Previous page 1 2 3 4 Next page